Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe
- PMID: 17764927
- DOI: 10.1016/j.ejca.2007.07.015
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe
Abstract
This investigation highlighted the risk of cancer in 8074 HIV-infected people and in 2875 transplant recipients in Italy and France. Observed and expected numbers of cancer were compared through sex- and age-standardised incidence ratios (SIRs) and 95% confidence intervals (CIs). After 15 years of follow-up, the cumulative probability of cancer was 14.7% in transplant recipients and 13.3% in HIV-positives. The SIRs for all cancers were 9.8 in HIV-positives and 2.2 in transplants. Kaposi's sarcoma (SIR=451 in HIV-positives, 125 in transplants) and non-Hodgkin lymphoma (SIR=62 and 11.1, respectively) were the most common cancers. A significantly increased SIR for liver cancer also emerged in both groups. The risk of lung cancer was significantly elevated in heart transplant recipients (SIR=2.8), and of borderline statistical significance in HIV-positive people (95% CI:0.9-2.8). Immune depression entails a two-fold increased overall risk of cancers, mainly related to cancers associated with a viral aetiology.
Similar articles
-
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.Transplant Proc. 2006 Dec;38(10):3533-5. doi: 10.1016/j.transproceed.2006.10.144. Transplant Proc. 2006. PMID: 17175324
-
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.J Natl Cancer Inst. 2005 Mar 16;97(6):425-32. doi: 10.1093/jnci/dji072. J Natl Cancer Inst. 2005. PMID: 15770006
-
Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups.Methods Mol Biol. 2009;471:409-19. doi: 10.1007/978-1-59745-416-2_20. Methods Mol Biol. 2009. PMID: 19109791
-
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.Lancet. 2007 Jul 7;370(9581):59-67. doi: 10.1016/S0140-6736(07)61050-2. Lancet. 2007. PMID: 17617273 Review.
-
De novo malignancies after liver transplantation: a major cause of late death.Liver Transpl. 2001 Nov;7(11 Suppl 1):S109-18. doi: 10.1053/jlts.2001.28645. Liver Transpl. 2001. PMID: 11689783 Review.
Cited by
-
Primary care of the renal transplant patient.J Gen Intern Med. 2010 Jul;25(7):731-40. doi: 10.1007/s11606-010-1354-5. Epub 2010 Apr 27. J Gen Intern Med. 2010. PMID: 20422302 Free PMC article. Review.
-
Increased Early Cancer Diagnosis: Unveiling Immune-Cancer Biology to Explain Clinical "Overdiagnosis".Cancers (Basel). 2023 Feb 10;15(4):1139. doi: 10.3390/cancers15041139. Cancers (Basel). 2023. PMID: 36831482 Free PMC article.
-
Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?Curr Opin HIV AIDS. 2009 Jan;4(1):42-51. doi: 10.1097/COH.0b013e32831a9875. Curr Opin HIV AIDS. 2009. PMID: 19339938 Free PMC article.
-
A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale.Int J Cancer. 2021 Jan 1;148(1):38-47. doi: 10.1002/ijc.33185. Epub 2020 Jul 29. Int J Cancer. 2021. PMID: 32621759 Free PMC article.
-
Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.Mol Clin Oncol. 2016 Sep;5(3):315-325. doi: 10.3892/mco.2016.952. Epub 2016 Jul 7. Mol Clin Oncol. 2016. PMID: 27602224 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical